Merck & Co., Inc. is 115.5x more valuable than IDEAYA Biosciences, Inc. by market capitalization ($294.03 B vs $2.55 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | IDYA | MRK |
|---|---|---|
| Market cap | $2.55 B | $294.03 B |
| US-listed rank | #1951 | #45 |
| Revenue (latest FY) | $218.71M | $65.01B |
| Net income (latest FY) | -$113.70M | $18.25B |
| Net margin | -52.0% | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 477 | 996 |
Merck & Co., Inc. is 115.5x more valuable than IDEAYA Biosciences, Inc. by market capitalization ($294.03 B vs $2.55 B).
In their latest fiscal years, IDEAYA Biosciences, Inc. reported $218.71M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: IDEAYA Biosciences, Inc. and Merck & Co., Inc., or browse the full rankings.